What does current research say about starting hormone replacement therapy before age fifty versus waiting until the onset of vasomotor symptoms?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What does current research say about starting hormone replacement therapy before age fifty versus waiting until the onset of vasomotor symptoms?
4 real searches · 1 real-search pass
2025 2026 menopause hormone therapy timing hypothesis initiation before symptoms asymptomatic women guideline evidence age 50Google ↗
OBSERVED
North American Menopause Society 2022 hormone therapy position statement timing age 60 10 years menopause benefits risksGoogle ↗
OBSERVED
ACOG hormone therapy menopause prevention chronic disease asymptomatic women early menopause before age 45 recommendationsGoogle ↗
OBSERVED
ELITE trial early versus late hormone therapy carotid intima media thickness KEEPS trial cardiovascular menopause timingGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 4 queries…
Searches and sources
ChatGPT4 real searches · gpt-6
2025 2026 menopause hormone therapy timing hypothesis initiation before symptoms asymptomatic women guideline evidence age 50 Google ↗
North American Menopause Society 2022 hormone therapy position statement timing age 60 10 years menopause benefits risks Google ↗
ACOG hormone therapy menopause prevention chronic disease asymptomatic women early menopause before age 45 recommendations Google ↗
ELITE trial early versus late hormone therapy carotid intima media thickness KEEPS trial cardiovascular menopause timing Google ↗
- Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis · pubmed.ncbi.nlm.nih.gov
- The 2022 hormone therapy position statement of The North American Menopause Society · pubmed.ncbi.nlm.nih.gov
- Recommendation: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions · uspreventiveservicestaskforce.org
- ACOG Clinical Practice Guideline: Management of Menopause-Related Vasomotor, Sleep, and Mood Symptoms. · pubmed.ncbi.nlm.nih.gov
- Evidence-based guideline: premature ovarian insufficiency‡,‡ | Human Reproduction Open · academic.oup.com
- Hormone Therapy in Primary Ovarian Insufficiency · acog.org
- Committee Opinion No. 698 Summary: Hormone Therapy in Primary Ovarian Insufficiency. · pubmed.ncbi.nlm.nih.gov
- Final Recommendation Statement: Hormone Therapy in Postmenopausal Persons: Primary Prevention of Chronic Conditions · uspreventiveservicestaskforce.org
Queries
4 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2025 2026 menopause hormone therapy timing hypothesis initiation before symptoms asymptomatic women guideline evidence age 50 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
North American Menopause Society 2022 hormone therapy position statement timing age 60 10 years menopause benefits risks OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ACOG hormone therapy menopause prevention chronic disease asymptomatic women early menopause before age 45 recommendations OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
ELITE trial early versus late hormone therapy carotid intima media thickness KEEPS trial cardiovascular menopause timing OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |